Treatment and prevention of secondary injury after trauma or damage to the central nervous system

Details for Australian Patent Application No. 2010286450 (hide)

Owner Schneider, E.

Inventors Schneider, Eric B.

Agent Baxter IP

Pub. Number AU-A-2010286450

PCT Pub. Number WO2011/026060

Priority 61/238,453 31.08.09 US

Filing date 31 August 2010

Wipo publication date 3 March 2011

International Classifications

A61K 31/36 (2006.01)

A61K 31/365 (2006.01) - Lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/026060 Priority application(s): WO2011/026060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286451-Vapor-phase decarbonylation process

2010286449-Vapor phase decarbonylation process